Cargando…

Editorial: Targeted Immunotherapy for Cancer

Detalles Bibliográficos
Autor principal:	Williams, Williams V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041305/ https://www.ncbi.nlm.nih.gov/pubmed/35496284 http://dx.doi.org/10.3389/fphar.2022.894681

Ejemplares similares

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more
por: Wang, Zhi-Bin, et al.
Publicado: (2023)

Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
por: Jiang, Aimin, et al.
Publicado: (2023)

Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy
por: Zhang, Chunxue, et al.
Publicado: (2023)

Editorial: New immunotherapeutic and pharmacological targets and strategies in haematological malignancies
por: Williams, Mark Thomas Shaw, et al.
Publicado: (2023)

Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go?
por: Li, Xuefeng, et al.
Publicado: (2022)

Editorial: Chemosensitizing effect of natural products against cancers: Applications in enhancing chemotherapy and immunotherapy
por: Roy, Nand K., et al.
Publicado: (2022)

Editorial: Natural products modulate the sensitivity of cancer to anti-PD-1 based immunotherapy
por: Chamcheu, Jean Christopher, et al.
Publicado: (2023)

Editorial: Metabolic Intervention Based on Functional Biomaterial Strategy to Potentiate Cancer Immunotherapy, Volume I
por: Feng, Bing
Publicado: (2022)

Editorial: Therapeutic targeting of splicing variants in cancer
por: Sarvari, Pouya, et al.
Publicado: (2023)

Editorial: Targeted Subcellular Delivery of Anti-cancer Agents
por: Jans, David A., et al.
Publicado: (2019)

Editorial: Novel small molecules in targeted cancer therapy
por: Li, Rong, et al.
Publicado: (2023)

Editorial: Leveraging pharmacovigilance data mining with “the patient” in mind
por: Gossell-Williams, Maxine, et al.
Publicado: (2022)

Immunotherapy targeting cytokines in neuropathic pain
por: Lees, Justin G., et al.
Publicado: (2013)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021)

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
por: Zulfiqar, Bilal, et al.
Publicado: (2022)

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer
por: Huang, Xu, et al.
Publicado: (2023)

Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche
por: Jin, Ming-Zhu, et al.
Publicado: (2023)

Editorial: Targeting triple negative breast cancer by natural compounds
por: Kumar, Shashank, et al.
Publicado: (2023)

Editorial: Advances in drug-induced diseases
por: Liu, Yao, et al.
Publicado: (2023)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
por: Zhou, Fanfan, et al.
Publicado: (2022)

Editorial: Matricellular Receptors As Potential Targets in Anti-Cancer Therapeutic Strategies
por: Emonard, Hervé, et al.
Publicado: (2016)

Editorial: Anti-cancer effects of botanical drugs targeting the tumor microenvironment
por: Cheng, Chien-shan, et al.
Publicado: (2023)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022)

Editorial: New Advances in RNA Targeting
por: Ilinskaya, Olga, et al.
Publicado: (2020)

Editorial: Targeting the Chemoattractant System in Inflammation
por: Hosoya, Tadashi, et al.
Publicado: (2021)

Editorial: Metalloenzymes: Potential Drug Targets
por: Iqbal, Jamshed, et al.
Publicado: (2021)

Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma
por: Zheng, Yang, et al.
Publicado: (2023)

Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy
por: Zhu, Jianshu, et al.
Publicado: (2023)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
por: Heudobler, Daniel, et al.
Publicado: (2021)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
por: Su, Chao-Yue, et al.
Publicado: (2023)

Activation of cancer immunotherapy by nanomedicine
por: Wang, Lijuan, et al.
Publicado: (2022)

Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking
por: Liu, Luyan, et al.
Publicado: (2022)

Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
por: Du, Peixin, et al.
Publicado: (2022)

Editorial: Evolution of phytochemicals and phytotherapies in the treatment and management of cancer: targeted strategies in cancer precision medicine
por: Adnan, Mohd, et al.
Publicado: (2023)

Editorial: Orphan GPCRs As Emerging Drug Targets
por: Fang, Ye, et al.
Publicado: (2015)

Editorial: Novel Targets and Biomarkers in Solid Tumors
por: Shi, Zhi, et al.
Publicado: (2019)

Editorial: Targeting TNF/TNFR signaling pathways
por: Pan, Liqiang, et al.
Publicado: (2023)

Editorial: Targeting inflammation to prevent complications in stroke
por: Varela, Lourdes M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4ns6ca4e6g4s3117p3fg5rfpbb